This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Eczema industry.
What is the anticipated market size of the eczema industry over the next few years?
The eczema market size has grown strongly in recent years. It will grow from $16.41 billion in 2024 to $17.81 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of autoimmune diseases, rising eczema cases, increasing approvals from authorities, rising incidences of air pollutants, and increasing burden of allergic reactions.
The eczema market size is expected to see strong growth in the next few years. It will grow to $24.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for treatment atopic dermatitis, increasing operational activities, increasing awareness of eczema, increasing incorporation of biologics, increasing adoption of telemedicine platform. Major trends in the forecast period include strategic collaboration, emerging therapies, injectable drugs, and personalized medicine.
Download Your Free Sample PDF:
What emerging drivers are expected to shape the future of the eczema market?
The increasing prevalence of autoimmune disorders is expected to propel the growth of the eczema market going forward. Autoimmune disorders refer to conditions in which the body's immune system mistakenly attacks its healthy cells, tissues, or organs, leading to inflammation and damage. The increasing prevalence of autoimmune disorders is attributed to genetic susceptibility, environmental factors, infections, dietary changes, and lifestyle factors such as stress and exposure to pollutants. Autoimmune diseases, such as psoriasis, lupus, and rheumatoid arthritis, are linked to dysregulated immune responses, making individuals more susceptible to eczema and other inflammatory skin conditions. For instance, in November 2024, according to the Versorgungsatlas.de, a Germany-based organization, in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, leading to a raw prevalence rate of 8.61%. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the eczema market.
What emerging segments are shaping the future landscape of the eczema industry?
The eczema market covered in this report is segmented –
1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types
2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy
3) By Age Group: Children, Adults, Elderly
4) By End User: Hospitals Or Clinics, Dermatology Centers, Home Care, Pharmacies
Subsegments:
1) By Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies
2) By Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses
3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors
4) By Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema
View The Full Market Report:
How are emerging trends transforming the eczema market dynamics?
Major companies operating in the eczema market are focusing on the development of innovative products, such as eczema care creams, to enhance treatment effectiveness and meet consumer demand for advanced skincare solutions. Eczema care cream is a specialized skincare product designed to soothe, hydrate, and protect the skin affected by eczema, helping to reduce itching, inflammation, and dryness. For instance, in September 2024, Dove, a UK-based personal care brand, launched a new Eczema Care range for babies, which includes the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. The Baby Dove Eczema Care range offers several unique features tailored for infants with eczema. Firstly, the products are formulated with 100% skin-natural nutrients, ensuring they are gentle on sensitive skin. They contain colloidal oatmeal (1.0%), a key ingredient for soothing irritation and maintaining moisture.
How are key players in the eczema market strengthening their market position?
Major companies operating in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc
Which geographic areas are contributing significantly to the growth of the eczema sector?
North America was the largest region in the eczema market in 2024. The regions covered in the eczema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Eczema Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Eczema Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment